(BUSINESS WIRE)--GeneFluidics is commercializing a novel technology platform that integrates bionanotechnology and microfluidics. The platform's components, which include a reader and disposable sensors and cartridges, rapidly detect and quantify the presence of target genetic material, proteins, and small molecules in raw samples without the use of target amplification methods such as PCR. Based in high-throughput plastic injection molding and other low-cost manufacturing methods, the GeneFluidics platform will dramatically reduce the cost of molecular analysis.
Company: GeneFluidics
Headquarters Address: 2540 Corporate Place, Suite B101 Monterey Park, CA 91754
Main Telephone: 323-269-0900
Website: http://www.genefluidics.com
Type of Organization: Private
Industry: Health: Biotechnology
Key Executives: CEO: Vincent Gau Vice President: John Kibler
Corporate Development
Contact: John Kibler Phone: 323-269-0900 Email: jkibler@genefluidics.com
Contact:
GeneFluidics
Source: GeneFluidics